Skip to main content

Naglazyme 1 mg/ml injectable

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION

Contents of the leaflet

  1. Introduction
  2. What is Naglazyme and what is it used for
  3. What you need to know before you use Naglazyme
  4. How to use Naglazyme
  5. Possible side effects
  6. Storage of Naglazyme
  7. Contents of the pack and other information

Introduction

PROSPECT: INFORMATION FORTHEUSER

Naglazyme 1 mg/ml concentrate for solution for infusion

Galsulfase

This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the pack:

  1. What is Naglazyme and what is it used for
  2. What you need to know before you use Naglazyme
  3. How to use Naglazyme
  4. Possible side effects
  5. Storage of Naglazyme
  6. Contents of the pack and other information

1. What is Naglazyme and what is it used for

Naglazyme is used to treat patients with MPS VI (Mucopolysaccharidosis VI).

People with MPS VI have low or no levels of an enzyme called N-acetylgalactosamine 4-sulfatase that breaks down specific substances (glycosaminoglycans) in the body. As a result, these substances are not broken down and processed by the body as they should be. They accumulate in many tissues in the body, causing the symptoms of MPS VI.

HowNaglazyme works

This medicine contains a recombinant enzyme called galsulfase that can replace the natural enzyme that is missing in patients with MPS VI. It has been shown that treatment improves walking and stair-climbing ability, and reduces the levels of glycosaminoglycans in the body. This medicine may improve the symptoms of MPS VI.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Naglazyme

Do not useNaglazyme

  • If you have experienced severe or life-threatening allergic reactions (hypersensitivity) to galsulfase or any of the other components of Naglazyme and readministration of the medicine was not successful.

Warnings and precautions

  • If you are treated with Naglazyme, you may develop infusion-related reactions. An infusion-related reaction is any adverse event that occurs during the infusion or up to the end of the infusion day (see section 4 “Possible side effects”). If you experience such a reaction, you should contact your doctor immediately.
  • If you experience an allergic reaction, your doctor may slow down or stop your infusion. Your doctor may also give you additional medicines to treat any allergic reaction.
  • If you have a fever or difficulty breathing before using this medicine, consult your doctor about the possibility of delaying the infusion of Naglazyme.
    • If you have underlying heart disease, inform your doctor at any time while receiving treatment with Naglazyme. Your doctor may adjust the infusion based on this information.
  • This medicine has not been studied in patients with liver or kidney problems. Consult your doctor if you have renal or hepatic impairment.
  • Talk to your doctor if you experience muscle pain, numbness in your arms or legs, or any intestinal or urinary problems, as they may be caused by pressure on the spinal cord.

Other medicines and Naglazyme

Tell your doctor if you are using or have recently used other medicines, including those obtained without a prescription.

Pregnancy and breastfeeding

Naglazyme should not be administered during pregnancy, unless clearly necessary. Consult your doctor or pharmacist before using any medicine. It is not known whether galsulfase is excreted in breast milk, so breastfeeding should be discontinued during treatment with Naglazyme. Consult your doctor or pharmacist before using any medicine.

Driving and using machines

No studies have been performed on the effects on the ability to drive and use machines.

This medicine contains sodium

This medicine contains 0.8 mmol (18.4 mg) of sodium (main component of cooking/table salt) per 5 ml vial. This is equivalent to % of the maximum recommended daily intake of sodium for an adult and is administered in a sodium chloride 9 mg/ml solution for injection...

3. How to use Naglazyme

Your doctor or nurse will administer Naglazyme to you.

The dose you receive will depend on your body weight. The recommended dose is 1 mg/kg body weight, administered once a week by slow infusion into a vein (as an intravenous infusion). Each infusion will take approximately 4 hours. During the first hour, the infusion rate will be slow (approximately 2.5% of the total solution) and the remaining volume (approximately 97.5%) will be administered over the next 3 hours.

If you are given too much Naglazyme

Naglazyme is administered under the supervision of a nurse or doctor, who will ensure that the correct dose is administered and take action if necessary.

If you miss an infusion ofNaglazyme

If you have missed an infusion of Naglazyme, contact your doctor.

If you have any other questions about the use of this medicine, ask your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Side effects were mainly seen while patients were receiving the medicine or soon after (“infusion-related reactions”). The most serious side effects were facial swelling and fever (very common), prolonged intervals between breaths, difficulty breathing, asthma, and hives (common); and swelling of the tongue and throat, and severe allergic reaction to this medicine (with unknown frequency).

If you experience any of these reactions, tell your doctor immediately.You may need to receive additional medicines to prevent an allergic reaction (e.g. antihistamines or corticosteroids) or to reduce fever (antipyretics).

The most common symptoms of infusion-related reactions include fever, chills, rash, hives, and difficulty breathing.

Very common side effects (may affect more than 1 in 10 people):

  • Sore throat
  • Gastroenteritis
  • Decreased reflexes
  • Headache
  • Eye inflammation
  • Blurred vision
  • Hearing loss
  • Hypertension
  • Nasal congestion
  • Umbilical hernia
  • Vomiting
  • Nausea
  • Itching
  • Pain (in ears, abdominal, in joints, in chest)
  • General discomfort

Common side effects (may affect up to 1 in 10 people):

  • Tremor
  • Hypotension
  • Cough
  • Wheezing
  • Redness of the skin

Other side effects with unknown frequency:

  • Shock
  • Numbness
  • Decreased heart rate
  • Increased heart rate
  • Blue-tinged skin
  • Pale skin
  • Low oxygen in the blood
  • Rapid breathing

If you experience any of these symptoms, or any other symptoms that do not appear in this leaflet, tell your doctor immediately. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Naglazyme

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the vial after EXP. The expiry date is the last day of the month stated.

Unopened vials:

Store in a refrigerator (between 2 °C and 8 °C).

Do not freeze.

Diluted solutions: Chemical and physical stability has been demonstrated for up to 4 days at room temperature (23 °C - 27 °C).

To avoid microbial contamination, the product should be used immediately. If not used immediately, the in-use storage times and conditions are the responsibility of the user and normally should not exceed 24 hours at 2 °C - 8 °C, followed by up to 24 hours at room temperature (23 °C - 27 °C) during administration.

Do not use Naglazyme if you notice visible particles.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Naglazyme

  • The active substance is galsulfase. Each milliliter of Naglazyme contains 1 mg of galsulfase. A 5 ml vial contains 5 mg of galsulfase. Galsulfase is recombinant human N-acetylgalactosamine 4-sulfatase produced in Chinese hamster ovary (CHO) cells modified by genetic engineering.
  • The other ingredients are: sodium chloride, sodium phosphate monobasic monohydrate, disodium phosphate heptahydrate, polysorbate 80, water for injections.

Appearance and pack contents

Naglazyme is supplied as a concentrate for solution for infusion. The concentrate varies from transparent to slightly opalescent and from colorless to pale yellow, and should not contain visible particles. The solution must be diluted before it can be infused.

Pack sizes:1 and 6 vials. Not all pack sizes may be marketed.

Marketing authorisation holder

BioMarin International Limited

Shanbally, Ringaskiddy

County Cork, P43 R298

Ireland

Manufacturer

BioMarin International Limited

Shanbally, Ringaskiddy

County Cork, P43 R298

Ireland

Date of last revision of this leaflet: MM/YYYY

This medicine has been authorised under “exceptional circumstances”.

This means that due to the rarity of your disease, it has not been possible to obtain complete information on this medicine.

The European Medicines Agency will review any new information that becomes available every year and this leaflet will be updated as necessary.

Detailed information on this medicine is available on the website of the European Medicines Agency http://www.ema.europa.eu/. It also provides links to other websites on rare diseases and orphan medicines.

<-------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Naglazyme should not be mixed with any other medicine in the same infusion, except for those mentioned below.

Each vial of Naglazyme is for single use. The concentrate for solution for infusion must be diluted with a sodium chloride 9 mg/ml (0.9%) solution for infusion using an aseptic technique. It is recommended that the diluted Naglazyme solution be administered to patients using an infusion set equipped with an in-line filter (0.2 μm).

Disposal of unused medicine and all materials that have come into contact with it should be done in accordance with local regulations.

Preparation of Naglazyme infusion (using aseptic technique)

The number of vials to be diluted will be determined based on the patient's weight and will be removed from the refrigerator approximately 20 minutes before to allow them to reach room temperature.

Prior to dilution, each vial will be visually inspected for the presence of particles or color changes. The solution, which varies from transparent to slightly opalescent and from colorless to pale yellow, should be free of visible particles.

A volume of sodium chloride 9 mg/ml (0.9%) solution for infusion will be withdrawn from a 250 ml infusion bag and discarded, equal to the total volume of Naglazyme to be added. The use of 100 ml infusion bags may be considered in patients sensitive to fluid volume overload and weighing less than 20 kg; in such cases, the infusion rate (ml/min) will be reduced so that the total duration is not less than 4 hours. If 100 ml bags are used, the volume of Naglazyme may be added directly to the infusion bag.

The volume of Naglazyme will be added slowly to the sodium chloride 9 mg/ml (0.9%) solution for infusion.

The solution will be gently mixed for infusion.

The solution will be visually inspected for particles before use. Only clear and colorless solutions without visible particles should be used.

Online doctors for NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Andreea Mateescu

Paediatrics8 years of experience

Dr Andreea Mateescu is a board-certified paediatrician with 7 years of clinical experience. She graduated from Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, and completed her paediatric residency at INSMC Alessandrescu-Rusescu. She also holds additional training in general ultrasound diagnostics.

Dr Mateescu focuses on providing high-quality, evidence-based medical care for children, with a strong emphasis on prevention, healthy development, and long-term wellbeing. She believes that clear, empathetic communication with both children and parents is essential for building trust and ensuring effective care.

Online consultations with Dr Mateescu are suitable for:

  • preventive check-ups and monitoring of growth and development;
  • vaccination planning, including personalised and catch-up schedules;
  • assessment of psychomotor, emotional, and physical development;
  • diagnosis and management of acute and chronic paediatric conditions;
  • nutritional guidance for infants and children, including formula selection when medically indicated;
  • care for children with complex or rare conditions;
  • practical guidance and ongoing support for parents.
Dr Mateescu works with patience, empathy, and professionalism, ensuring that each child receives attentive, individualised care. Her goal is to support healthy, balanced development while helping parents feel confident and well-informed at every stage of their child’s care.
Book a video appointment
€60
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(1)

Cristina Andrada Brazo

General medicineSleep medicine16 years of experience
Licence no. 264505958

Dr. Cristina Andrada Brazo is a highly experienced Spanish physician with more than 15 years of clinical practice in emergency medicine, urgent care, and clinical neurophysiology. She provides professional online medical consultations for patients across Spain, helping both residents and international visitors receive timely medical advice, diagnosis, treatment recommendations, and electronic prescriptions when clinically appropriate.

As a licensed physician fully integrated with the Spanish electronic prescription system, Dr. Andrada can issue legally valid e-prescriptions following a medical assessment during an online consultation. Whether you need help with an acute illness, prescription renewal, neurological symptoms, or travel-related healthcare, she offers convenient, patient-centered medical care without the need to visit a clinic.

Dr. Andrada combines extensive emergency medicine experience with advanced expertise in neurology, epilepsy, sleep medicine, and headache disorders. Her international clinical background includes several years working in Switzerland, where she collaborated with multidisciplinary teams in emergency departments and neurology services. This experience strengthened her commitment to evidence-based medicine, compassionate communication, and high-quality patient care.

She graduated in Medicine from the University of Seville and completed her residency in Clinical Neurophysiology at Hospital Virgen de la Salud and the National Hospital for Paraplegics in Toledo. She currently works as a Clinical Neurophysiology Specialist at Hospital San Pedro in Logroño.

To further expand her expertise, Dr. Andrada completed several postgraduate qualifications, including Master's degrees in Sleep Physiology and Medicine, Medical Professionalism and Clinical Practice, Epilepsy, and Clinical Management.

Patients appreciate her thorough consultations, practical treatment recommendations, and empathetic approach. She speaks Spanish, French, and Portuguese, allowing her to communicate comfortably with patients from different backgrounds.

Conditions Dr. Cristina Andrada Treats Online

Dr. Andrada provides online consultations for a wide range of common medical conditions, including:

  • Fever, flu, COVID-19 symptoms, sore throat and respiratory infections
  • Sinusitis, bronchitis, cough and seasonal allergies
  • Urinary tract infections (UTIs)
  • Migraine and tension headaches
  • Dizziness and vertigo
  • Epilepsy and seizure follow-up
  • Sleep disorders, including insomnia and circadian rhythm disturbances
  • Heartburn, gastritis, diarrhea and constipation
  • Back pain, muscle injuries and joint pain
  • Minor skin infections and allergic reactions
  • Fatigue and general medical assessment
  • Prescription renewals for appropriate chronic treatments
  • Follow-up consultations after surgery or previous medical treatment
  • Travel medicine advice and preventive healthcare
  • Interpretation of laboratory results and medical reports

If your condition requires urgent in-person assessment or emergency care, Dr. Andrada will advise you on the most appropriate next steps.

Book an Online Consultation

Book a secure online consultation with Dr. Cristina Andrada Brazo through Oladoctor and receive professional medical advice from an experienced Spanish physician without leaving home. Online appointments are available for adults throughout Spain, with fast access to medical care and electronic prescriptions whenever clinically indicated.

Book a video appointment
€56

Frequently Asked Questions

NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION is manufactured by Biomarin International Limited. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, NAGLAZYME 1 mg/ml CONCENTRATE FOR INFUSION SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance () include ALDURAZYME, 100 U/mL Concentrate for Infusion Solution, BRINEURA 150 MG SOLUTION FOR INFUSION, CEREZYME 400 units powder for concentrate for infusion solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media